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Abstract
The Sydney Medically Supervised Injecting Centre (MSIC) is a supervised injecting facility (SIF) where people who
inject drugs (PWID) can do so legally, under health professional supervision. The majority of clients have low levels
of education and employment, high rates of incarceration and unstable housing and poor social networks, and
70 % do not access local health services. These factors increase the risk of poor mental health, and it has been
documented that PWID have elevated rates of mood, anxiety, personality and psychotic disorders; post-traumatic
stress disorder (PTSD); and higher rates of trauma exposure, suicidality and self-harm. The current study is the first
to investigate the mental health among clients of a SIF. Validated instruments to examine clients’ mental health,
social networks and trauma histories were administered to 50 frequently attending clients by a mental health nurse.
The majority of respondents were unemployed, homeless and had a history of incarceration, and 82 % report they
had been diagnosed with a mental health problem, but only 24 % report they were receiving treatment. Respondents
had poor social networks, had poorer mental health symptoms compared to US inpatients and had experienced
multiple traumatic events, and a high number of respondents had scores indicative of PTSD. These results highlight the
need for mental health clinicians to be employed in SIFs and other drug consumption rooms (DCRs) to assist clients to
address their mental health and psychosocial needs, particularly in light of the fact that these services are often the
only places these PWID engage with in an ongoing way.
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Background
The Sydney Medically Supervised Injecting Centre (MSIC)
is a supervised injecting facility (SIF) where people who
inject drugs (PWID) do so legally, under health profes-
sional supervision. Operational since May 2001, MSIC
aims to reduce death and injury from drug overdose and
reduce harm associated with injecting drug use. As in May
2015, MSIC had supervised more than 930,000 injections
and managed over 5925 overdoses without a fatality.
MSIC has more than 15,000 registered clients, of which
approximately 600 clients attend in a typical month and
70 % of whom had not accessed local health services prior
to MSIC registration [1, 2]. Engaging this “hard-to-reach”
population, staff aim to enhance access to drug treatment
and psychosocial and health services, including mental
health, with over 11,500 referrals provided as in May 2015.
The broad population of PWID is characterised by low
educational attainment and employment rates [3] and
high rates of incarceration and unstable housing [4].
Such attributes are exaggerated among MSIC’s clients
[2], of whom 92 % report unemployment and 65 % report
unstable housing [4]. Additionally, PWID commonly have
limited social networks, as rejection by non-using friends
[5] often leads to social isolation [6], a well-documented
risk factor for poor mental health [7]. Such social deter-
minants of health are associated with mental health
problems [8, 9], and consistent with these associations,
PWID have documented elevated rates of mood, anx-
iety, personality and psychotic disorders [10, 11]; post-
traumatic stress disorder (PTSD) [12]; and suicidality
and self-harm [10, 12]. Trauma exposures such as being
witness to serious injury or death, being involved in a
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life-threatening accident, being threatened with a weapon,
being held captive or kidnapped [13] and being sexually
abused as a child [14] are commonly experienced by
people with substance dependence. These traumas usually
occur before the onset of substance abuse disorders [13]
and increase the risk of later mental health problems [14].
Despite high rates of mental health problems, PWID
often encounter multiple barriers to accessing relevant
services, ranging from clinician attitudes to the systems
within which they work [15, 16]. Early evaluation of
MSIC found that of those PWID registered to use the
service, only 42 % were clients of local services targeted
to their needs [2]. Likewise, qualitative research suggests
substantial barriers to accessing treatment among MSIC
clients, including unwillingness precipitated by stigma
and discrimination [17]. MSIC clients are a hard-to-
reach, and sometimes invisible, population who are un-
likely to be captured by previous investigations of the
mental health of people who use drugs.
By attracting a disengaged population, and offering
services which facilitate sustained client contact, MSIC
is uniquely placed to assess and engage with PWID re-
garding mental health. The present study builds on our
formative research [17] by utilising validated instruments
to examine clients’ mental health, social networks and
trauma histories. There are now approximately 100 SIFs
and drug consumption rooms (DCRs) around the world,
and this study is the first to apply a structured, quantita-
tive approach to mental health assessment among clients
of these services.
Methods
The study was approved by the Human Research Ethics
Committee of South Eastern Sydney Local Health Dis-
trict. MSIC’s mental health nurse (author MG) assessed
the mental health of 50 frequent attendees, defined as
the 100 clients visiting most often between October and
December 2014 (visit count range 29–321). It should be
noted that within a typical month approximately 600 in-
dividual clients make up the majority of all visits to the
service [1]. The first 50 of these 100 clients to present all
agreed to participate and were reimbursed with an AU$40
voucher.
Structured questionnaires assessed demographic char-
acteristics. Unstable accommodation was defined as pri-
mary (“sleeping rough”), secondary (staying with friends/
relatives or in specialist homelessness services) and tertiary
(neither secure lease nor private facilities) homelessness
[4]. A broad mental health history was collected, including
suicide, self-harm, previous mental health diagnoses, treat-
ment and prescription of psychiatric medication. Lubben’s
Social Network Scale-6 (LSNS-6) was used to assess
perceived social support from family and friends [18]. The
Behavior and Symptom Identification Scale (BASIS-24)
provided a measure of recent difficulty in the symptom and
functioning domains that underlie the need for mental
health services [19]. BASIS-24 scores range from 0 to 5,
with 5 the highest score indicating severe mental health
symptoms and functional difficulties [19]. Trauma exposure
and PTSD were assessed with the Composite International
Diagnostic Interview (CIDI) version 2.1 and the PTSD
Checklist (PCL-C), respectively [20, 21]. The CIDI mea-
sures lifetime and childhood exposure to traumatic events
[20], and the PCL-C 17 items are added to obtain a possible
score range from 17 to 85, and a cut-off of 50 is a predictor
of a PTSD diagnosis [21].
Results and discussion
Participants (N = 50) had a mean age of 42 years (SD
9.2); 70 % were male, 26 % female and 4 % transgender;
and 92 % were unemployed. Sixteen percent of partici-
pants identified as Aboriginal and/or Torres Strait Is-
lander; 62 % reported current unstable accommodation;
and 70 % reported a history of incarceration.
Eighty-two percent reported that “a doctor had ever
told (them) that (they) had a mental health problem”
(Table 1). Self-reported diagnoses included the following:
mood disorders including depression (48 %) and bipolar
disorder (16 %); anxiety disorders including anxiety
(36 %), panic disorder/attacks (4 %), obsessive-compulsive
disorder (4 %) and generalised anxiety disorder (2 %);
psychotic illnesses including schizophrenia (22 %), drug-
induced psychosis (6 %) and schizoaffective disorder (4 %);
PTSD (12 %); attention deficit hyperactivity disorder
(10 %); and personality disorders including borderline per-
sonality disorder (4 %) and antisocial personality disorder
(4 %). Among the 54 % of participants who reported a
previous suicide attempt, a median of 2 attempts (range
1–12) had been made. One third of the sample re-
ported a history of self-harm.
Just 24 % of participants reported currently receiving
mental health treatment, including 8 % from a psychiatrist/
Table 1 Mental health indicators reported by MSIC frequently
attending clients (N = 50)
Mental health indicator % sample
Any mental health diagnosis by a doctor (lifetime) 82
Mood disorder (lifetime) 64
Anxiety disorder (lifetime) 46
Psychotic illness (lifetime) 32
Post-traumatic stress disorder (lifetime) 12
Attention deficit hyperactivity disorder (lifetime) 10
Personality disorder (lifetime) 8
History of suicide attempt/s 54
History of self-harm 44
Currently receiving support from mental health services 24
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psychiatric registrar and 2 % from a general practitioner.
Forty-four percent reported current psychiatric medication
prescription, including antipsychotics (20 %), antidepres-
sants (20 %) and mood stabilisers (4 %). In this open-ended
format (“Are you prescribed any psychiatric medications?
Specify which”), no participants reported a current benzodi-
azepine prescription.
Social networks, isolation and mental health symptoms
Mean score on the LSNS-6 was 9 (SD 6.2); 70 % re-
ceived a score <12 indicative of social isolation. Mean
total score on the BASIS-24 was 2.59 (SD 0.79), and
Table 2 outlines the subscale means, which are compared
to a US mental health inpatient population.
Trauma
Ninety-six percent of the sample had experienced a trau-
matic event in their lives (M 4.54, SD 2.45), including a
mean of 3.04 traumatic exposures before the age of 16 (SD
2.50) (Table 2). Mean PCL-C score was 44.54 (SD 17.33),
with 36 % scoring above 50, indicative of current PTSD.
This study, the first to apply a structured, quantitative
approach to the assessment of mental health among cli-
ents of SIFs and DCRs, documented elevated lifetime
rates of mental health disorders among Sydney MSIC
clients. Over 80 % reported having ever received a men-
tal health diagnosis from a doctor, most commonly
mood (64 %), anxiety (46 %) and psychotic disorders
(32 %). More than one half (54 %) reported attempted
suicide and 34 % history of self-harm. These estimates
are considerably higher than those in the Australian gen-
eral population (46 % lifetime prevalence) [22] and at
the upper end of lifetime prevalence estimates reported
for Australians in substance use treatment (46–100 %)
[23]. Further highlighting MSIC clients’ poor mental
health were BASIS-24 scores, a measure of symptom
and functioning difficulties in the preceding week. The
mean BASIS-24 score for MSIC clients (2.59) was sub-
stantially higher than the benchmark figure for patients
admitted to US mental health facilities (1.85), as were a
number of the mean subscale scores including psychosis
(2.01 vs 1.11) and substance use (3.03 vs 1.85) [19].
These scores highlight that MSIC clients have more
severe mental health symptoms and functioning than
patients within a mental health facility [19].
Results clearly suggest substantial mental health needs,
yet 76 % of participants were not currently accessing
mental health treatment. There was also substantial
disconnect between MSIC clients reporting prescrip-
tion of psychiatric medication (44 %) and having a
qualified prescriber (10 %). Given the high rates of anxiety
disorders among participants, the absence of prescription
benzodiazepine use was unexpected. This result may
reflect recent changes to benzodiazepine scheduling by
Australia’s Therapeutic Goods Administration [24] and/or
the normalisation of benzodiazepine use among MSIC cli-
ents and their ready illicit access to this class of drugs.
Given the robust relationships between mental health
and social determinants including education, employ-
ment and housing [8, 9], and in light of the demographic
characteristics of MSIC clients [2] and in this study, ele-
vated prevalence of untreated mental health disorders
among this group is unsurprising. Seventy percent of
this sample was deemed socially isolated by the LSNS-6
[18]. As an integral component of health and well-being,
MSIC clients’ lack of social connectedness is undoubt-
edly inextricably linked to their poor mental health [7].
Consistent with the literature, trauma exposure and
PTSD as assessed by the PCL-C were highly prevalent
[12]. Given that past trauma is strongly associated with
mental health problems [14], the high rates of exposure
of participants to traumatic events such as death, vio-
lence, sexual violence and natural disasters, including
during childhood, are also consistent with the patterns
of poor mental health among MSIC clients (Table 3).
Table 2 BASIS-24 (mental health symptoms over the past week)
(N = 50)
MSIC US inpatient
Mean SD Mean SD
Total 2.59 0.79 1.85 0.83
Depression/functioning 2.64 1.00 2.22 1.13
Interpersonal problems 2.78 0.87 1.76 1.06
Self-harm 1.62 0.89 1.15 1.25
Emotional labiality 2.78 1.01 1.96 1.13
Psychosis 2.01 1.05 1.11 1.15
Substance abuse 3.03 0.62 1.85 0.83
Table 3 Lifetime and childhood exposure to traumatic events




to age 16 years
Witnessed someone badly injured
or killed
78 42
Seriously physically attacked or
assaulted
72 56
Threatened with a weapon, held
captive or kidnapped
68 32
Involved in a life-threatening accident 58 30
Molested 52 46
Raped 42 40
Involved in a fire, flood or
natural disaster
34 24
Tortured or victim of terrorist 34 26
Direct combat experience in a war 12 6
Events listed in the table are verbatim from the CIDI version 2.1 [20]
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However, the discrepancy between the proportion of cli-
ents having ever received a diagnosis of PTSD (12 %)
and the proportion screening positive for current PTSD
on the PCL-C (50 %) indicates that there may be marked
underdiagnosis of this disorder, and possibly other disor-
ders, among clients of SIFs and DCRs.
This cross-sectional study is unable to delineate the
extent to which mental health problems among MSIC
clients are a cause or a consequence of drug use. An-
other limitation of this study is its sample size of 50. In
a previous study of street-based injectors in Kings Cross
(MSIC’s location), indicators of social marginalisation,
including unstable housing, unemployment and public
injecting, were significantly associated with psychological
distress, while indicators of drug use were not [25]. Re-
gardless of the temporal sequencing of trauma, social
isolation, mental health disorders and drug use, the fact
remains that despite their reluctance to engage with
other health services, clients suffer poor mental health.
As a service that facilitates sustained, ongoing contact
with clients, MSIC is uniquely placed to assess and en-
gage with PWID around mental health issues. Indeed,
this potential is reflected both in the visit numbers of
the frequent attendees described here (up to 321 within
a 3-month period) and in the 100 % response rate of cli-
ents invited to participate in this study.
Conclusions
Specialised mental health services should be essential
partners in the establishment of SIFs, and the ever-
increasing number of DCRs, due to the high levels of
mental distress among PWID and the multiple traumatic
events they experience. Based on our findings, we recom-
mend that, where possible, SIFs and DCRs implement
multiple strategies to enhance mental health outcomes, in-
cluding the following:
 Fostering good working relationships with local mental
health services to create effective referral pathways
 Employment of a specialised mental health clinician
 Ongoing staff training in mental health, risk
assessments and trauma informed care
 Establishing regular onsite psychiatric clinics for
clients unwilling to access mainstream health services
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